Prelude Therapeutics Stock Pattern Recognition Doji Star

PRLD Stock  USD 0.97  0.06  5.83%   
Prelude Therapeutics pattern recognition tool provides the execution environment for running the Doji Star recognition and other technical functions against Prelude Therapeutics. Prelude Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Doji Star recognition function is designed to identify and follow existing trends. Prelude Therapeutics momentum indicators are usually used to generate trading rules based on assumptions that Prelude Therapeutics trends in prices tend to continue for long periods.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eleven with a total number of output elements of fifty. The function did not return any valid pattern recognition events for the selected time horizon. Doji Star may indicate a high probability reversal condition for Prelude Therapeutics.

Prelude Therapeutics Technical Analysis Modules

Most technical analysis of Prelude Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Prelude from various momentum indicators to cycle indicators. When you analyze Prelude charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Prelude Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Prelude Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Prelude Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Prelude Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Prelude Therapeutics's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Prelude Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Prelude Therapeutics, we also check how macroeconomic factors affect Prelude Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Current Ratio15.379.4210.798.74
Net Debt To EBITDA0.270.240.06410.0609
Hype
Prediction
LowEstimatedHigh
0.050.977.60
Details
Intrinsic
Valuation
LowRealHigh
0.050.937.56
Details
Naive
Forecast
LowNextHigh
0.020.937.56
Details
5 Analysts
Consensus
LowTargetHigh
7.057.758.60
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Momentum Idea
Momentum
Invested over 50 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Banking Idea
Banking
Invested over 40 shares
Blockchain Idea
Blockchain
Invested few shares
Impulse Idea
Impulse
Invested few shares
FinTech Idea
FinTech
Invested few shares
Trump Equities Idea
Trump Equities
Invested few shares
When determining whether Prelude Therapeutics is a strong investment it is important to analyze Prelude Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Prelude Therapeutics' future performance. For an informed investment choice regarding Prelude Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prelude Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Prelude Stock refer to our How to Trade Prelude Stock guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prelude Therapeutics. If investors know Prelude will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prelude Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.77)
Revenue Per Share
0.04
Return On Assets
(0.39)
Return On Equity
(0.67)
The market value of Prelude Therapeutics is measured differently than its book value, which is the value of Prelude that is recorded on the company's balance sheet. Investors also form their own opinion of Prelude Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Prelude Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prelude Therapeutics' market value can be influenced by many factors that don't directly affect Prelude Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prelude Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Prelude Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prelude Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.